A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study-Reference-Cited by-同舟云学术

A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study

Published:2024-08-06 Issue:6 Volume:150 Page:509-511
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Netuka Ivan¹,Tucanova Zuzana¹,Ivak Peter¹^ORCID,Gregor Stanislav¹,Kolesar Dushan Michael¹,Marek Tomas¹,Melenovsky Vojtech¹^ORCID,Binova Jana¹,Dorazilova Zora¹,Hegarova Marketa¹,Podolec Martina¹,Riha Hynek¹^ORCID,Connors Jean M.²^ORCID,Mehra Mandeep R.²^ORCID

Affiliation:

1. Institute for Clinical and Experimental Medicine, Prague, Czech Republic (I.N., Z.T., P.I., S.G., D.M.K., T.M., V.M., J.B., Z.D., M.H., M.P., H.R.).

2. Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (J.M.C., M.R.M.).

Funder

Abbott | Abbott Vascular

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure

2. Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients

3. Apixaban: Alternative Anticoagulation for HeartMate 3 Ventricular Assist Device

4. Shah P. Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) study. Presented at THT 2024; Boston MA; March 5 2024.

5. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy for Mechanical Circulatory Support: Time to Throw the Baby (Warfarin) Out With the Bathwater (Aspirin)?;Circulation: Heart Failure;2024-08

2. Antithrombotic Strategies With Left Ventricular Assist Devices;Journal of Cardiac Failure;2024-08

3. Comparing Apixaban With Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices;The American Journal of Cardiology;2024-08

4. Highlights From the International Society for Heart and Lung Transplantation, 2024;Journal of Cardiac Failure;2024-07